- Home
- MDXH vs SOL Comparison
MDXH vs SOL Comparison
Compare MDXH & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- SOL
- Stock Information
- Founded
- MDXH 2003
- SOL 2005
- Country
- MDXH Belgium
- SOL United States
- Employees
- MDXH N/A
- SOL N/A
- Industry
- MDXH
- SOL Semiconductors
- Sector
- MDXH
- SOL Technology
- Exchange
- MDXH Nasdaq
- SOL Nasdaq
- Market Cap
- MDXH 84.6M
- SOL 94.9M
- IPO Year
- MDXH 2021
- SOL 2008
- Fundamental
- Price
- MDXH $2.44
- SOL $1.92
- Analyst Decision
- MDXH Buy
- SOL Strong Buy
- Analyst Count
- MDXH 1
- SOL 2
- Target Price
- MDXH $6.00
- SOL $4.50
- AVG Volume (30 Days)
- MDXH 54.9K
- SOL 401.5K
- Earning Date
- MDXH 08-20-2025
- SOL 08-19-2025
- Dividend Yield
- MDXH N/A
- SOL N/A
- EPS Growth
- MDXH N/A
- SOL N/A
- EPS
- MDXH N/A
- SOL N/A
- Revenue
- MDXH $94,507,000.00
- SOL $85,621,000.00
- Revenue This Year
- MDXH $23.51
- SOL N/A
- Revenue Next Year
- MDXH $17.68
- SOL $45.37
- P/E Ratio
- MDXH N/A
- SOL N/A
- Revenue Growth
- MDXH 25.46
- SOL N/A
- 52 Week Low
- MDXH $1.35
- SOL $1.04
- 52 Week High
- MDXH $3.50
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- MDXH 64.50
- SOL 60.14
- Support Level
- MDXH $2.17
- SOL $1.84
- Resistance Level
- MDXH $2.35
- SOL $1.94
- Average True Range (ATR)
- MDXH 0.07
- SOL 0.02
- MACD
- MDXH 0.01
- SOL -0.01
- Stochastic Oscillator
- MDXH 96.90
- SOL 61.11
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.